Windlas Biotech Limited

NSE: WINDLAS · Unclassified

₹994.40+7.94%06 Nov 2026

Ask the data

Instant answers about Windlas Biotech Limited — computed from its filings, no language model

Market cap₹2,099 cr

Current price₹994.40

High / Low₹1,155 / ₹706

P/E62.1

P/B3.61

Book value₹275.2

ROE5.8%

ROCE15.0%

Debt / equity0.05

Dividend yield0.58%

EPS (TTM)₹16.01

Face value₹5

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY22	FY23	FY24	FY25	FY26
Revenue	465.9	513.1	631.0	759.9	904.1
EBITDA	52.4	60.2	78.2	94.1	104.7
Operating margin	11.3%	11.7%	12.4%	12.4%	11.6%
Interest	1.4	0.8	1.1	4.4	4.8
Depreciation	12.2	12.4	13.4	28.0	30.7
Profit before tax	45.6	57.0	77.1	79.8	87.0
Tax	7.5	14.4	18.9	18.8	20.5
Net profit	37.9	42.6	0.0	0.0	66.5
EPS ₹	18.80	19.70	27.97	29.19	31.60
Operating cash flow	9.1	61.0	109.0	68.2	104.9
Capex	14.8	70.9	37.7	52.2	67.7
Dividend paid	0.0	7.6	8.3	11.5	12.2
Total assets	—	529.0	626.2	760.5	907.4
Equity	—	402.3	449.9	505.8	580.8

Quarterly performance

last 20 quarters · ₹ crore

showing latest 8 of 20 periods

	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26
Revenue	111.0	115.2	117.6	122.1	119.9	132.7	119.7	140.7	144.8	152.7	162.2	171.3	175.2	187.0	195.0	202.7	210.1	222.4	233.1	238.5
Operating profit	12.4	13.2	13.0	13.8	13.8	16.1	13.9	16.4	17.1	18.7	20.3	22.0	20.9	23.1	24.6	25.6	26.5	28.6	24.4	25.3
Operating margin	11.2%	11.4%	11.1%	11.3%	11.5%	12.1%	11.7%	11.7%	11.8%	12.2%	12.5%	12.8%	11.9%	12.3%	12.6%	12.6%	12.6%	12.8%	10.5%	10.6%
Other income	0.7	1.2	1.8	3.0	2.9	2.6	2.2	2.3	2.6	3.2	3.2	4.4	4.1	4.8	4.1	4.9	5.2	3.6	4.6	4.3
Interest	0.5	0.4	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.3	0.3	0.3	0.5	1.1	1.5	1.3	1.1	1.0	1.3	1.5
Depreciation	3.0	3.1	3.1	2.9	2.8	2.9	3.1	3.6	3.2	3.3	3.4	3.5	6.2	6.5	6.9	8.3	7.5	7.6	7.7	8.0
Profit before tax	9.6	10.9	11.5	13.7	13.5	15.6	12.8	15.0	16.3	18.3	19.8	22.6	18.3	20.3	20.3	20.8	23.3	23.6	20.0	20.2
Tax	2.9	2.6	3.2	-1.1	3.7	3.4	3.6	3.6	4.3	4.3	4.7	5.6	4.8	4.6	4.8	4.5	5.6	5.8	5.0	4.2
Net profit	6.4	8.3	8.4	14.9	9.8	12.2	0.0	11.4	12.1	14.0	15.1	0.0	13.5	0.0	0.0	0.0	0.0	17.8	0.0	16.0
EPS ₹	3.67	4.11	3.81	6.97	4.50	5.59	4.23	5.37	5.79	6.75	7.26	8.17	6.47	7.49	7.45	7.77	8.43	8.48	7.12	7.58
Revenue YoY	—	—	—	—	8.1%	15.2%	1.8%	15.2%	20.7%	15.0%	35.5%	21.7%	21.0%	22.5%	20.2%	18.4%	19.9%	18.9%	19.5%	17.7%
Profit YoY	—	—	—	—	53.8%	46.9%	-100.0%	-23.1%	23.1%	15.1%	—	-100.0%	11.8%	-100.0%	-100.0%	—	-100.0%	—	—	—

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 17 periods

	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26
ROE	—	—	11.1%	9.0%	8.3%	8.9%	9.0%	12.6%	9.2%	9.5%	6.1%	2.9%	2.7%	0.0%	3.3%	3.3%	5.8%
ROCE	—	—	13.5%	13.8%	14.4%	15.0%	15.1%	16.8%	17.4%	17.9%	17.1%	17.5%	15.8%	16.8%	16.6%	16.5%	15.0%
Net margin	8.1%	8.7%	9.2%	7.5%	6.5%	6.6%	6.7%	8.8%	6.5%	6.4%	4.1%	1.9%	1.8%	0.0%	2.1%	2.0%	3.7%
EBITDA margin	11.2%	11.3%	11.5%	11.7%	11.7%	11.8%	11.9%	12.1%	12.4%	12.4%	12.4%	12.4%	12.4%	12.6%	12.7%	12.1%	11.6%
Debt / equity	—	—	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.03	0.03	0.05	0.05	0.05	0.05	0.05
Interest coverage	33.09	39.40	56.99	61.49	72.29	87.71	74.54	71.20	71.08	59.56	38.35	25.50	19.21	18.11	19.07	19.69	18.97
Asset turnover	—	—	0.95	0.95	0.97	1.02	0.98	1.05	1.01	1.06	0.93	0.98	1.00	1.05	1.02	1.07	1.00

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	10.9	10.5	10.4	10.4	10.4	10.5	10.5	10.6
Other equity / reserves	397.4	391.8	405.8	439.5	460.8	495.3	523.5	570.3
Total equity	408.3	402.3	416.2	449.9	471.2	505.8	534.1	580.8
Borrowings	0.6	0.4	2.2	0.1	15.2	27.1	25.9	29.9
Current liabilities	106.7	121.2	148.7	171.8	270.9	249.4	273.3	320.9
Non-current liabilities	3.2	5.5	5.1	4.5	4.8	5.2	6.8	5.6
Total assets	518.2	529.0	570.0	626.2	746.9	760.5	814.2	907.4
Property, plant & equipment	85.0	102.6	99.6	169.5	161.5	195.5	187.5	187.2
Capital work-in-progress	13.6	13.8	57.0	5.7	31.5	3.2	24.2	56.2
Investments	78.9	106.5	141.2	173.4	181.6	223.4	245.6	268.4
Inventories	82.2	74.7	61.1	62.2	82.0	81.4	70.3	61.8
Receivables	105.3	116.9	127.4	136.3	186.8	166.9	197.8	227.4
Cash & equivalents	21.9	3.7	1.1	5.3	0.4	0.4	0.2	0.5

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	9.1	61.0	109.0	68.2	104.9
Cash from investing	-154.6	-14.1	-92.1	-74.1	-91.8
Cash from financing	130.1	-43.7	-15.3	1.0	-13.0
Capex	14.8	70.9	37.7	52.2	67.7
Free cash flow	-5.7	-9.9	71.3	16.0	37.3
Dividends paid	0.0	7.6	8.3	11.5	12.2

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹187.2 cr21%

CWIP

₹56.2 cr6%

Investments

₹268.4 cr30%

Inventories

₹61.8 cr7%

Receivables

₹227.4 cr25%

Cash & equivalents

₹0.5 cr0%

Other assets

₹105.9 cr12%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Windlas Biotech Limited	2,099	994.40	62.1	3.61	5.8%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-2.7%

6 months+16.4%

1 year+4.0%

3Y CAGR+39.4%

5Y CAGR+26.7%

10Y CAGR—

50-day avg₹1,010.87

200-day avg₹872.01

RSI (14)60

FAQs

What is the share price of Windlas Biotech Limited?

Windlas Biotech Limited (WINDLAS) closed at ₹994.40 on NSE on 06 Nov 2026.

What is the market cap of Windlas Biotech Limited?

₹2,099 crore at the latest close.

What is the P/E ratio of Windlas Biotech Limited?

62.1, on trailing-twelve-month earnings from its filings.

How fast is Windlas Biotech Limited growing?

Windlas Biotech Limited: revenue has compounded at 20.8% a year over three years; net profit at 16.0% a year. Latest-quarter revenue is up 17.7% year on year.

How profitable is Windlas Biotech Limited?

On a trailing-twelve-month basis return on equity is 5.8%, return on capital employed 15.0%, operating margin 11.6%, net margin 3.7%.

How much debt does Windlas Biotech Limited have?

Windlas Biotech Limited is lightly geared: debt to equity is 0.05 with borrowings of ₹30 cr against cash of ₹1 cr (balance sheet of 2026-03-31). Operating profit covers interest 19.0 times.

Financials parsed from Windlas Biotech Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '21, annual from FY22, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.